Phenanthro[9,10-b]quinoxaline | Solubility of Things

Identification

Molecular formula

C₁₈H₁₀N₂

CAS number

84-11-7

IUPAC name

phenanthro[9,10-b]quinoxaline

State

At room temperature, Phenanthro[9,10-b]quinoxaline is typically found in a solid state, owing to its aromatic planar structure and stable molecular interactions.

Melting point (Celsius)

141.00

Melting point (Kelvin)

414.15

Boiling point (Celsius)

495.00

Boiling point (Kelvin)

768.15

General information

Molecular weight

230.28g/mol

Molar mass

230.2540g/mol

Density

1.2500g/cm³

Appearence

Phenanthro[9,10-b]quinoxaline typically appears as a yellow crystalline solid. Its distinct crystalline structure can be attributed to the planar aromatic systems within its molecular framework. These compounds are usually handled in powdered form, indicating their crystalline nature.

Comment on solubility

Solubility of Phenanthro[9,10-b]quinoxaline

Phemanthro[9,10-b]quinoxaline (C₁₄H₉N₃) presents interesting solubility characteristics that are important for its applications in various chemical contexts. Understanding the solubility of this compound can be pivotal in fields such as organic synthesis and pharmaceutical formulation.

Here are some key points regarding its solubility:

Solvent Dependency: The solubility of phenanthro[9,10-b]quinoxaline varies significantly depending on the solvent used. It tends to be more soluble in organic solvents such as dimethyl sulfoxide (DMSO) and chloroform.
Limited Water Solubility: This compound exhibits relatively low solubility in water. As a generalized rule, many organic compounds with heterocyclic structures, especially those with large aromatic systems, show weak interactions with polar solvents like water.
Temperature Influence: As with numerous organic compounds, solubility is often enhanced at elevated temperatures, prompting further investigations into thermal effects on its dissolving behavior.

In conclusion, while phenanthro[9,10-b]quinoxaline demonstrates notable solubility in specific organic solvents, its limited solubility in water underscores its specialized usage in non-aqueous environments. As highlighted, understanding the solvent interactions and conditions can lead to more effective applications in chemistry.

Interesting facts

Interesting Facts about Phenanthro[9,10-b]quinoxaline

Phemanthro[9,10-b]quinoxaline is a fascinating compound that has garnered attention in various fields of research owing to its unique structural characteristics and potential applications. Here are some interesting facts to note:

Structural Complexity: The compound features a complex polycyclic aromatic structure which enhances its electronic properties, making it intriguing for study in materials science.
Photophysical Properties: Phenanthro[9,10-b]quinoxaline exhibits strong photoluminescence. This quality makes it suitable for applications in organic light-emitting diodes (OLEDs) and other optoelectronic devices.
Biological Activities: Research indicates that this compound has potential anti-cancer properties, leading to investigations into its effectiveness as a therapeutic agent. Its interactions at the molecular level present thrilling prospects for medicinal chemistry.
Synthetic Versatility: Different synthetic routes have been developed to create phenanthro[9,10-b]quinoxaline, allowing chemists to modify its properties for specific applications. This adaptability could lead to advancements in material design and drug development.
Research Application: It is widely studied in the field of organic semiconductors, where its ability to serve as a charge transport layer shows promise in improving device performance.

As you can see, the study of phenanthro[9,10-b]quinoxaline is not just about its chemical structure; it intersects with various scientific disciplines, making it a truly interdisciplinary compound worth exploring in-depth.

Synonyms

Dibenzo[a,c]phenazine

215-64-5

Phenanthro[9,10-b]quinoxaline

DIBENZO(a,c)PHENAZINE

1,2:3,4-Dibenzophenazine

1,2,3,4-Dibenzphenazine

Phenanthro-9',10':2,3-quinoxaline

Phenanthro(9,10-b)quinoxaline

9,14-Diazadibenz(a,c)anthracene

FA46H2Q0KS

Dibenz[a,c]phenazine

9,14-Diazadibenz[a,c]anthracene

NSC 6945

NSC-6945

UNII-FA46H2Q0KS

BRN 0217169

AI3-24100

DTXSID50175833

NSC6945

Dibenz(a,c)phenazine

5-23-10-00183 (Beilstein Handbook Reference)

DIBENZO-(A,C)-PHENAZINE

Phenanthrazine (VAN)

9,c]anthracene

DBPZ cpd

1,4-Dibenzophenazine

1,3,4-Dibenzphenazine

1,2,3,4-Dibenzophenazin

CBDivE_001593

Phenanthro-9',3-quinoxaline

SCHEMBL732274

phenanthro[9,10-b]chinoxalin

DTXCID2098324

MFCD00022300

STK015716

AKOS000629546

WLN: T J6 D6 C666 BN QNJ

DB-243385

G85845

Z56791881

F0243-0007

15,22-diazapentacyclo[12.8.0.0?,?.0?,??.0??,??]docosa-1(14),2(7),3,5,8(13),9,11,15,17,19,21-undecaene